ATC code B06

= ATC Code B06 =

The Anatomical Therapeutic Chemical (ATC) Classification System is a system used for the classification of drugs and other medical products. The ATC code B06 is a specific category within this system that pertains to "Other hematological agents." This category includes drugs that are used for various hematological purposes but do not fit into the more specific categories of hematological agents.

Overview

ATC code B06 is part of the broader ATC code B, which is designated for "Blood and blood forming organs." The B06 category is a miscellaneous group that includes agents with diverse mechanisms of action and therapeutic uses related to blood and hematological conditions.

Subcategories

The B06 category is further divided into subcategories to classify specific types of agents. As of the latest update, the following subcategories are included under B06:

B06A Other hematological agents

This subcategory includes various agents that are used for hematological purposes but do not belong to the more specific categories of blood and blood-forming organ agents. These agents may have unique mechanisms of action or be used for specific conditions that are not covered by other ATC codes.

Examples of Agents in B06

While the B06 category is not as populated as some other ATC categories, it includes important agents used in clinical practice. Some examples include:

• Erythropoiesis-stimulating agents (ESAs): These are used to stimulate the production of red blood cells in conditions such as anemia associated with chronic kidney disease or chemotherapy.
• Iron chelators: Used to treat iron overload conditions, such as those resulting from repeated blood transfusions.

Clinical Applications

The agents classified under ATC code B06 are used in a variety of clinical settings, often for conditions that involve abnormalities in blood cell production or function. For example:

• Anemia management: Some agents in this category are used to manage different types of anemia, including those caused by chronic diseases or nutritional deficiencies.
• Iron overload treatment: Iron chelators are crucial in managing iron overload, which can occur in patients receiving frequent blood transfusions, such as those with thalassemia or sickle cell disease.

Conclusion

ATC code B06 serves as a catch-all category for hematological agents that do not fit neatly into other classifications. It includes a diverse range of drugs with important roles in managing blood-related conditions. Understanding the specific agents and their applications within this category is essential for healthcare professionals involved in the treatment of hematological disorders.

References

• WHO Collaborating Centre for Drug Statistics Methodology. (2023). ATC/DDD Index 2023. Retrieved from [1]
• National Institutes of Health. (2023). MedlinePlus: Blood Disorders. Retrieved from [2]